Clinical trials
Sepsis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 5 |
| Samsung Medical Center | 2 |
| Asahi Kasei Pharma America Corporation | 1 |
| Asan Medical Center | 1 |
| CHA University | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Dohern Kym | 1 |
| Eisai Inc. | 1 |
| Gil Joon Suh | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 28 |
| Shock, Septic | 9 |
| Acute Kidney Injury | 2 |
| Bacteremia | 2 |
| Heart Arrest | 2 |
| Shock | 2 |
| Burns | 1 |
| Candidemia | 1 |
| Candidiasis | 1 |
| Candidiasis, Invasive | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.